Ozempic, Wegovy: 4 Factors May Influence Weight Loss Results
Summary by Medical News Today
3 Articles
3 Articles
A three-year follow-up study of millions of patients shows that patients taking the currently widely used diabetes and weight loss drugs (GLP-1 receptor agonists) may have a doubled risk of developing eye diseases. Although the absolute risk is not high, the potential impact cannot be ignored due to the large number of users.
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium